Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on chiral phosphoric acid catalysis, asymmetric synthesis, high enantioselectivity. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover how this novel chiral catalyst enables 99% ee synthesis with 90% yield, reducing R&D costs and supply chain risks for oncology drug development.
Discover high-purity axial chiral cyclopentenyl indole-naphthyl compounds with 99% ee for PC-3 cancer cell cytotoxicity. Optimize your drug development with scalable synthesis.